Associate Director-Brand Management at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

(Details regarding specific requirements are not provided in the original job description.)

Responsibilities

Lead Taltz AS indication strategy development and execution, including generating indication strategy to reflect clear growth drivers
Gain deep customer insights and utilize them to guide Taltz AS brand strategy
Differentiate Taltz AS by defining clear Sales and Brand Positioning (SABP) and delivering sharp data and messaging to differentiate from competitors
Lead TL engagement and belief/behavior change in Taltz AS (Rheumatology), including customer solutions and communication strategies
Lead Taltz AS planning by developing and managing comprehensive planning, including customer plans, business plans, and operational plans with clear measurements (e.g., ATU, quarterly assessment)
Collaborate with cross-functional teams to integrate Taltz AS, Olumiant RA, and other potential indications into the overall Rheumatology strategy and tactics
Manage and own the budget for Rheumatology initiatives

Skills

Brand Management

Indication Strategy

Customer Insights

Sales and Brand Positioning

Budget Management

Cross-functional Collaboration

Rheumatology Strategy

Business Planning

Market Differentiation

Pharma Marketing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free